Hexagon Capital Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-5,959
| Closed | -$330K | – | 1471 |
|
2025
Q1 | $330K | Buy |
5,959
+238
| +4% | +$13.2K | 0.06% | 143 |
|
2024
Q4 | $276K | Buy |
5,721
+365
| +7% | +$17.6K | 0.05% | 166 |
|
2024
Q3 | $309K | Buy |
5,356
+255
| +5% | +$14.7K | 0.06% | 149 |
|
2024
Q2 | $248K | Buy |
5,101
+267
| +6% | +$13K | 0.05% | 169 |
|
2024
Q1 | $235K | Sell |
4,834
-159
| -3% | -$7.73K | 0.05% | 181 |
|
2023
Q4 | $248K | Buy |
4,993
+984
| +25% | +$48.9K | 0.06% | 164 |
|
2023
Q3 | $215K | Buy |
4,009
+495
| +14% | +$26.6K | 0.06% | 163 |
|
2023
Q2 | $189K | Buy |
3,514
+672
| +24% | +$36.2K | 0.05% | 171 |
|
2023
Q1 | $155K | Sell |
2,842
-481
| -14% | -$26.2K | 0.04% | 189 |
|
2022
Q4 | $161K | Sell |
3,323
-147
| -4% | -$7.12K | 0.05% | 176 |
|
2022
Q3 | $132K | Buy |
3,470
+1,213
| +54% | +$46.1K | 0.04% | 199 |
|
2022
Q2 | $113K | Buy |
2,257
+767
| +51% | +$38.4K | 0.03% | 249 |
|
2022
Q1 | $76K | Hold |
1,490
| – | – | 0.02% | 309 |
|
2021
Q4 | $75K | Hold |
1,490
| – | – | 0.02% | 305 |
|
2021
Q3 | $72K | Sell |
1,490
-20
| -1% | -$966 | 0.02% | 296 |
|
2021
Q2 | $80K | Hold |
1,510
| – | – | 0.02% | 269 |
|
2021
Q1 | $74K | Buy |
1,510
+39
| +3% | +$1.91K | 0.02% | 268 |
|
2020
Q4 | $71K | Sell |
1,471
-950
| -39% | -$45.9K | 0.02% | 236 |
|
2020
Q3 | $112K | Buy |
+2,421
| New | +$112K | 0.04% | 166 |
|